Actively Recruiting
Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
Led by University Hospital Tuebingen · Updated on 2024-12-06
30
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
"Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcoma" is a prospective study with additional translational research using preoperative and postoperative tissue, blood sampling and advanced imaging.
CONDITIONS
Official Title
Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Planned histological confirmation for especially high-risk soft tissue sarcoma via open sampling
- Indication for neoadjuvant multimodal therapy (radiation and locoregional hyperthermia, optionally with simultaneous chemotherapy)
- Planned resection at a department of the CWS
- Age > 18 years
- Ability to consent
- For imaging study: Treatment on the combined MR hyperthermia device
You will not qualify if you...
- Age < 18 years
- Poor understanding (language etc.)
- Lack of reconnaissance ability
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Tuebingen
Tübingen, Baden-Wurttemberg, Germany, 72076
Actively Recruiting
Research Team
F
Franziska Eckert, MD, Prof.
CONTACT
V
Vlatko Potkrajcic, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here